The largest database of trusted experimental protocols

Corticosterone hemisuccinate

Manufactured by Steraloids
Sourced in United States

Corticosterone hemisuccinate is a chemical compound commonly used in laboratory environments. It is a derivative of the steroid hormone corticosterone, which plays a role in the regulation of various physiological processes. This product is intended for research and laboratory applications.

Automatically generated - may contain errors

3 protocols using corticosterone hemisuccinate

1

Corticosterone Treatment in Male Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Corticosterone treatment was as per our published protocols [13 (link), 14 (link)]. Briefly, the Cort group of male mice was given 25 µg/mL corticosterone hemisuccinate (Steraloids Inc., Newport, RI, USA) in their drinking water, changed twice a week, for 4 weeks. Control (CT) male mice received the same drinking water, without corticosterone added.
+ Open protocol
+ Expand
2

Pharmacological Reagents for In Vivo Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drugs were dissolved in a 0.9% saline solution. Saline, isoflurane, and sodium brevital were from Butler Schein (Alsip, IL). Cocaine HCl and Yohimbine hydrochloride were from Sigma Aldrich (St. Louis, MO). Corticosterone Hemisuccinate was from Steraloids Inc. (Newport RI).
+ Open protocol
+ Expand
3

Alcohol and Corticosterone Administration Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Alcohol (95%) was diluted in distilled water to a concentration of 20% (v/v) and administered IG, with volumes varied by weight to obtain the desired dose. Corticosterone hemisuccinate (4-pregnen-11β, 21-DIOL-3, 20-DIONE 21-hemisuccinate; Steraloids, Newport, RI) was dissolved in tap water by addition of NaOH and neutralized with HCl, to a final pH of 7.0–7.4 (Besheer et al., 2012 (link), 2013 (link); Gourley & Taylor, 2009 (link)). (1R,4R,5S,6R)-4-Amino-2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylic acid disodium salt (LY379268; Tocris, Ellisville, Missouri), a highly selective (IC50~10 nM in the presence of LY341495; Imre, 2007 (link)) Group II (mGluR2/3) agonist, and (2S)-2-Amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid disodium salt (LY341495; Tocris, Ellisville, Missouri), a highly potent (Kd~0.8 nM) and selective Group II (mGluR2/3) antagonist, were dissolved in saline and injected at a volume of 1 mL/kg. The doses of the mGluR2/3 compounds were selected based on pilot studies in our lab and on previous work (Bäckstrom & Hyytiä, 2005 (link); Cannady et al., 2011 (link); Liechti et al., 2007 (link); Monn et al., 1999 (link); Sidhpura et al., 2010 (link); Wright, Arnold, Wheeler, Ornstein, & Schoepp, 2001 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!